Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020
September 15 2020 - 4:05PM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), today
announced that it will hold its 2020 Annual Meeting of Stockholders
(the “Annual Meeting”) solely by means of remote communication
(i.e., a virtual-only stockholder meeting). This change is to
protect the safety, health and well-being of its stockholders,
directors, employees and the public during the COVID-19 pandemic.
As previously announced, the Annual Meeting will be held
on Tuesday, October 20, 2020 at 10:00 a.m. PDT.
Stockholders will not be able to attend the
Annual Meeting in person at a physical location. However, the
virtual Annual Meeting will provide stockholders of record as of
the close of business on August 24, 2020, the ability to
participate, vote their shares and ask questions during the meeting
via audio webcast.
Despite the change to a virtual-only meeting,
the proxy card or voting instruction form, as applicable, included
with previously-distributed proxy materials will not be updated to
reflect the change from an in-person meeting to a virtual-only
meeting and may be used to vote shares in connection with the
Annual Meeting.
As provided in the company’s proxy materials, an
online portal is available to stockholders
at www.proxyvote.com where stockholders
can view and download the company’s proxy materials and fiscal year
2020 Annual Report and vote their shares in advance of the Annual
Meeting. Stockholders may vote their shares during the Annual
Meeting (up until the closing of the polls) by following the
instructions available
at www.virtualshareholdermeeting.com/CDMO2020 during
the meeting.
To be admitted to the virtual-only Annual
Meeting, stockholders should
visit www.virtualshareholdermeeting.com/CDMO2020 and
enter the 16-digit control number found on their Important Notice
Regarding the Availability of Proxy Materials, their proxy card or
the instructions that accompanied their proxy materials.
Below are additional details on how stockholders
can participate in the virtual-only Annual Meeting:
- Access the meeting platform beginning at 9:45 a.m.
PDT on October 20, 2020.
- Vote during the Annual Meeting by following the instructions
available on the meeting website during the meeting.
- Submit a question during the meeting by visiting
www.virtualshareholdermeeting.com/CDMO2020 and
entering the stockholder’s 16-digit control number and submitting
the question in the “Ask a Question” field.
- If any difficulties are encountered while accessing the virtual
meeting, contact the technical support number that will be posted
on the Virtual Shareholder Meeting log-in page. Technical support
will be available beginning at 9:45 a.m.
PDT on October 20, 2020 and will remain available
until the meeting has ended.
- A list of stockholders entitled to vote will be available for
inspection by stockholders of record for any legally valid purpose
related to the Annual Meeting during the Annual Meeting by
following the link provided when stockholders login
to www.virtualshareholdermeeting.com/CDMO2020
and for a period of ten days prior to the Annual Meeting by sending
a request to corpsecretary@avidbio.com.
Whether or not stockholders plan to attend the
virtual-only Annual Meeting, the company urges
stockholders to vote and submit their proxies in advance of the
meeting by one of the methods described in the proxy materials.
About Avid
Bioservices, Inc.
Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and CGMP manufacturing of biopharmaceutical drug
substances derived from mammalian cell culture. The company
provides a comprehensive range of process development, CGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With 27 years of
experience producing monoclonal antibodies and recombinant
proteins, Avid's services include CGMP clinical and commercial drug
substance manufacturing, bulk packaging, release and stability
testing and regulatory submissions support. For early-stage
programs the company provides a variety of process development
activities, including upstream and downstream development and
optimization, analytical methods development, testing and
characterization. The scope of our services ranges from
standalone process development projects to full development and
manufacturing programs through commercialization.
www.avidbio.com.
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024